Concord Drugs consolidated net profit declines 93.88% in the June 2024 quarter

Net profit of Concord Drugs declined 93.88% to Rs 0.03 crore in the quarter ended June 2024 as against Rs 0.49 crore during the previous quarter ended June 2023. Sales rose 30.18% to Rs 11.69 crore in the quarter ended June 2024 as against Rs 8.98 crore during the previous quarter ended June 2023.

Particulars	Quarter Ended
	Jun. 2024	Jun. 2023	% Var.
Sales	11.69	8.98	30
OPM %	7.10	16.26	-
PBDT	0.38	1.02	-63
PBT	0.04	0.64	-94
NP	0.03	0.49	-94